(UroToday.com) In a plenary session entitled “Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum” held in conjunction with the American Urologic Association Annual Meeting, Dr. Alicia Morgans explored the role of systemic treatment intensification in metastatic castration sensitive prostate cancer (mCPSC).